Antiviral Activity and Safety of Aplaviroc, a Ccr5 Antagonist, in Combination with Lopinavir/Ritonavir in Hiv-Infected, Therapy-Naive Patients: Results of the Epic Study (Ccr100136)
AuthID
P-003-NEW
P-003-NEW